Suppr超能文献

获得性免疫缺陷综合征患者的留置中心静脉导管感染

Indwelling central venous catheter infections in patients with acquired immune deficiency syndrome.

作者信息

Skoutelis A T, Murphy R L, MacDonell K B, VonRoenn J H, Sterkel C D, Phair J P

机构信息

Department of Medicine, Northwestern University Medical School, Chicago, Illinois 60611.

出版信息

J Acquir Immune Defic Syndr (1988). 1990;3(4):335-42.

PMID:2313561
Abstract

Indwelling central venous catheters are increasingly useful in the clinical management of patients with acquired immune deficiency syndrome (AIDS). To evaluate the risk of catheter infection in this group of patients, we reviewed the records of 299 patients with Hickman and Port-a-cath catheters. Patients were stratified into three groups: (a) AIDS (n = 54), (b) non-AIDS immunodeficiencies (n = 102), and (c) immunocompetent (n = 98). The rate of infection per 1,000 catheter days was 2.02, 0.41 (p less than 0.002), and 0.23 (p less than 0.002), respectively. Gram-positive cocci were the predominant isolate. Previous catheter infection and advanced AIDS (as determined by positive p24 antigen and low CD4+ number) were associated with increased risk of infection. Exit, tunnel, and fungal infections required catheter removal. The risk of infection and management were similar in Hickman and Port-a-cath catheters. The mortality was extremely low in all groups. However, the risk of infection associated with indwelling catheters was significantly higher in AIDS patients compared to patients with other immunodeficiencies.

摘要

留置中心静脉导管在获得性免疫缺陷综合征(AIDS)患者的临床管理中越来越有用。为了评估该组患者发生导管感染的风险,我们回顾了299例使用希克曼导管和植入式静脉输液港的患者的记录。患者被分为三组:(a)艾滋病组(n = 54),(b)非艾滋病免疫缺陷组(n = 102),以及(c)免疫功能正常组(n = 98)。每1000导管日的感染率分别为2.02、0.41(p < 0.002)和0.23(p < 0.002)。革兰氏阳性球菌是主要的分离菌。既往导管感染和晚期艾滋病(由p24抗原阳性和CD4 + 细胞数量低确定)与感染风险增加有关。出口、隧道和真菌感染需要拔除导管。希克曼导管和植入式静脉输液港的感染风险及管理相似。所有组的死亡率都极低。然而,与其他免疫缺陷患者相比,艾滋病患者留置导管相关的感染风险明显更高。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验